Nichols & Pratt Advisers LLP MA Sells 99,245 Shares of CVS Health Corporation $CVS

Nichols & Pratt Advisers LLP MA reduced its position in CVS Health Corporation (NYSE:CVS) by 96.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,183 shares of the pharmacy operator’s stock after selling 99,245 shares during the period. Nichols & Pratt Advisers LLP MA’s holdings in CVS Health were worth $240,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in CVS. Norges Bank purchased a new position in CVS Health in the 2nd quarter worth about $1,358,698,000. Invesco Ltd. grew its stake in shares of CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after acquiring an additional 3,118,626 shares during the period. Jennison Associates LLC raised its holdings in shares of CVS Health by 111.7% during the second quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock valued at $276,895,000 after purchasing an additional 2,117,798 shares during the last quarter. Vanguard Group Inc. lifted its position in CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after purchasing an additional 2,063,737 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in CVS Health by 153.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock worth $214,240,000 after purchasing an additional 1,878,217 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Up 1.2%

CVS stock opened at $75.43 on Tuesday. The business’s 50-day moving average price is $78.85 and its 200-day moving average price is $75.33. The stock has a market cap of $95.76 billion, a P/E ratio of 198.51, a PEG ratio of 0.69 and a beta of 0.50. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $53.36 and a twelve month high of $85.15.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CVS shares. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Evercore ISI increased their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Bank of America reduced their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Finally, Barclays raised their price objective on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.